OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 2
Data from combined, up to 2021-03-07.
| Vaccinated at 2021-03-07 (%) | Vaccinated at 2021-03-07 (n) | Population | Vaccinated at 2021-02-28 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 25.8% | 659,183 | 2,558,164 | 25.5% | 0.3% |
| Sex | Female | 27.7% | 410,935 | 1,481,438 | 27.4% | 0.3% |
| Male | 23.1% | 248,248 | 1,076,726 | 22.8% | 0.3% | |
| Ethnicity | White - British | 25.5% | 366,380 | 1,436,897 | 25.2% | 0.3% |
| White - Irish | 25.9% | 5,397 | 20,874 | 25.5% | 0.3% | |
| White - Any other White background | 24.5% | 13,482 | 55,041 | 24.1% | 0.4% | |
| Mixed - White and Black Caribbean | 29.8% | 1,099 | 3,689 | 28.7% | 1.1% | |
| Mixed - White and Black African | 21.6% | 252 | 1,169 | 21.6% | 0.0% | |
| Mixed - White and Asian | 24.1% | 315 | 1,309 | 23.5% | 0.5% | |
| Mixed - Any other mixed background | 25.7% | 602 | 2,345 | 25.1% | 0.6% | |
| Asian or Asian British - Indian | 24.1% | 7,903 | 32,788 | 23.6% | 0.5% | |
| Asian or Asian British - Pakistani | 32.2% | 5,390 | 16,723 | 30.7% | 1.5% | |
| Asian or Asian British - Bangladeshi | 34.1% | 1,666 | 4,879 | 32.3% | 1.9% | |
| Asian or Asian British - Any other Asian background | 24.9% | 2,891 | 11,592 | 24.3% | 0.6% | |
| Black or Black British - Caribbean | 30.7% | 7,161 | 23,352 | 29.3% | 1.4% | |
| Black or Black British - African | 25.6% | 2,212 | 8,638 | 24.1% | 1.5% | |
| Black or Black British - Any other Black background | 27.6% | 693 | 2,513 | 26.5% | 1.1% | |
| Other ethnic groups - Chinese | 23.7% | 973 | 4,102 | 22.9% | 0.9% | |
| Other ethnic groups - Any other ethnic group | 29.0% | 1,981 | 6,832 | 28.3% | 0.7% | |
| Patients with any other ethnicity code | 24.9% | 98,490 | 395,367 | 24.6% | 0.3% | |
| Ethnicity not stated | 28.9% | 4,788 | 16,576 | 28.4% | 0.5% | |
| Ethnicity not recorded | 26.8% | 137,389 | 513,394 | 26.5% | 0.3% | |
| Ethnicity (broad categories) | White | 25.5% | 385,273 | 1,512,819 | 25.2% | 0.3% |
| Mixed | 26.9% | 2,296 | 8,526 | 26.0% | 0.9% | |
| South Asian | 27.1% | 17,864 | 66,003 | 26.2% | 0.9% | |
| Black | 29.2% | 10,087 | 34,517 | 27.8% | 1.4% | |
| Other | 27.1% | 2,961 | 10,941 | 26.2% | 0.8% | |
| Unknown | 26.0% | 240,681 | 925,337 | 25.7% | 0.3% | |
| Index of Multiple Deprivation | 1 (most deprived) | 26.4% | 201,467 | 762,608 | 26.0% | 0.4% |
| 2 | 26.9% | 94,255 | 350,371 | 26.5% | 0.4% | |
| 3 | 26.2% | 115,766 | 441,896 | 25.9% | 0.3% | |
| 4 | 25.3% | 120,582 | 477,372 | 25.0% | 0.2% | |
| 5 (least deprived) | 24.2% | 122,367 | 506,184 | 24.0% | 0.2% | |
| Unknown | 24.0% | 4,732 | 19,719 | 23.7% | 0.3% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 26.7% | 492,107 | 1,844,640 | 26.3% | 0.3% |
| Patients with Immunosuppression | 25.2% | 27,888 | 110,747 | 24.9% | 0.3% | |
| Patients with CKD | 27.3% | 213,213 | 780,710 | 27.0% | 0.3% | |
| Patients who have Chronic Respiratory Disease | 26.6% | 81,529 | 306,635 | 26.3% | 0.3% | |
| Patients with Diabetes | 27.0% | 140,175 | 519,274 | 26.6% | 0.4% | |
| Patients with Chronic Liver disease | 25.9% | 12,054 | 46,606 | 25.5% | 0.4% | |
| Patients with CNS Disease (including Stroke/TIA) | 31.1% | 133,105 | 427,644 | 30.7% | 0.4% | |
| Patients with Chronic heart disease | 27.0% | 292,005 | 1,082,998 | 26.6% | 0.3% | |
| Patients with Asplenia or Dysfunction of the Spleen | 24.4% | 5,019 | 20,587 | 24.1% | 0.2% | |
| Patients with Wider Learning Disability | 45.7% | 595 | 1,302 | 44.6% | 1.1% | |
| Patients with Severe Mental Health | 37.2% | 6,475 | 17,402 | 36.4% | 0.8% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 29.9% | 225,953 | 755,370 | 29.5% | 0.4% |
| Patients with Morbid Obesity | 34.4% | 12,026 | 35,007 | 33.8% | 0.5% | |
| Patients who are pregnant | 28.3% | 91 | 322 | 26.1% | 2.2% |